Literature DB >> 16775838

A homozygous frameshift mutation in the ESCO2 gene: evidence of intertissue and interindividual variation in Nmd efficiency.

Nicoletta Resta1, Francesco Claudio Susca, Marilena C Di Giacomo, Alessandro Stella, Nenad Bukvic, Rosanna Bagnulo, Cristiano Simone, Ginevra Guanti.   

Abstract

Roberts syndrome (RS) is a rare disorder characterized by tetraphocomelia and several other clinical features. Cells from RS patients exhibit characteristic premature separation of heterochromatic region of many chromosomes and abnormalities in cell cycle. Mutations in the ESCO2 gene have recently been identified in 20 RS families. We performed mutational analysis of the ESCO2 gene in two fetuses diagnosed with RS and their normal parents. In both fetuses, we identified homozygosity for the c. 745_746delGT mutation, while the non-consanguineous parents were both heterozygous for the same mutation. Considering the position of the mutation identified, we carried out qualitative and quantitative real-time ESCO2 cDNA analysis on RNA isolated from CVS-stromal cells in one fetus, amniocytes in the second fetus, and lymphocytes from the heterozygous parents. The results of this analysis showed that despite the presence of a premature termination codon (PTC) 112 nucleotides upstream of the next exon3-exon4 junction, the mutant ESCO2 mRNA was present in both fetuses, albeit at low levels, indicating a partial resistance to nonsense mediated decay (NMD). Interestingly, when cells derived from the two fetuses were treated with an inhibitor of translation, they revealed the presence of tissue and individual variability in NMD efficiency, despite the identical mutational status. The existence of such a variation in the NMD efficiency could explain the broad intrafamilial and interfamilial variability in the clinical presentation of RS patients, and in other genetic diseases where nonsense mutations are responsible for most of the mutation load. Moreover, considering that a mutated full length mRNA was produced in both fetuses, we used Western blot analysis to demonstrate the absence of the ESCO2-truncated protein in cells derived from both fetuses and in a lymphoblastoid cell line derived from the parents. Copyright 2006 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16775838     DOI: 10.1002/jcp.20708

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  24 in total

1.  A cytogenetic study of hospital workers occupationally exposed to radionuclides in Serbia: premature centromere division as novel biomarker of exposure?

Authors:  Jelena Pajic; Boban Rakic; Dubravka Jovicic; Aleksandar Milovanovic
Journal:  Int Arch Occup Environ Health       Date:  2015-09-15       Impact factor: 3.015

Review 2.  Nonsense-mediated mRNA decay (NMD) in animal embryogenesis: to die or not to die, that is the question.

Authors:  Jungwook Hwang; Lynne E Maquat
Journal:  Curr Opin Genet Dev       Date:  2011-08       Impact factor: 5.578

3.  Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin.

Authors:  Liat Linde; Stephanie Boelz; Malka Nissim-Rafinia; Yifat S Oren; Michael Wilschanski; Yasmin Yaacov; Dov Virgilis; Gabriele Neu-Yilik; Andreas E Kulozik; Eitan Kerem; Batsheva Kerem
Journal:  J Clin Invest       Date:  2007-02-08       Impact factor: 14.808

Review 4.  Nonsense-mediated decay in genetic disease: friend or foe?

Authors:  Jake N Miller; David A Pearce
Journal:  Mutat Res Rev Mutat Res       Date:  2014-05-28       Impact factor: 5.657

5.  Characterization of novel CAPN3 isoforms in white blood cells: an alternative approach for limb-girdle muscular dystrophy 2A diagnosis.

Authors:  L Blázquez; M Azpitarte; A Sáenz; M Goicoechea; D Otaegui; X Ferrer; I Illa; E Gutierrez-Rivas; J J Vilchez; A López de Munain
Journal:  Neurogenetics       Date:  2008-06-19       Impact factor: 2.660

Review 6.  Nonsense-mediated mRNA decay: inter-individual variability and human disease.

Authors:  Lam Son Nguyen; Miles F Wilkinson; Jozef Gecz
Journal:  Neurosci Biobehav Rev       Date:  2013-11-14       Impact factor: 8.989

7.  Nonsense-mediated messenger RNA decay of survival motor neuron 1 causes spinal muscular atrophy.

Authors:  Lars Brichta; Lutz Garbes; Maria Jedrzejowska; Sushma-Nagaraja Grellscheid; Irmgard Holker; Katharina Zimmermann; Brunhilde Wirth
Journal:  Hum Genet       Date:  2008-01-03       Impact factor: 4.132

8.  Inhibition of SMG-8, a subunit of SMG-1 kinase, ameliorates nonsense-mediated mRNA decay-exacerbated mutant phenotypes without cytotoxicity.

Authors:  Fusako Usuki; Akio Yamashita; Tadafumi Shiraishi; Atsushi Shiga; Osamu Onodera; Itsuro Higuchi; Shigeo Ohno
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-27       Impact factor: 11.205

9.  The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes.

Authors:  Julie K Johnson; Nic Waddell; Georgia Chenevix-Trench
Journal:  BMC Cancer       Date:  2012-06-15       Impact factor: 4.430

10.  Olfactory stem cells, a new cellular model for studying molecular mechanisms underlying familial dysautonomia.

Authors:  Nathalie Boone; Béatrice Loriod; Aurélie Bergon; Oualid Sbai; Christine Formisano-Tréziny; Jean Gabert; Michel Khrestchatisky; Catherine Nguyen; François Féron; Felicia B Axelrod; El Chérif Ibrahim
Journal:  PLoS One       Date:  2010-12-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.